EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark Myriamed was filed as Word mark on 10/14/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 07/30/2022.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018578237 |
| Application date | October 14, 2021 |
| Publication date | April 22, 2022 |
| Entry date | July 30, 2022 |
| Expiration date | October 14, 2031 |
Trademark owner
Rudolf-Wissell-Straße 28a
37079 Göttingen
DE
37079 Göttingen
DE
Trademark representatives
Ganghoferstrasse 68b
80339 München
DE
goods and services
1
Chemicals for use in industry and science, in particular reagents for cultivation of cells and tissue; cells for research or for scientific purposes, namely, cells, in particular genetically modified cells, human cells and cells derived from induced pluripotent stem cells, in particular cardiomyocytes derived from human induced pluripotent stem cells, skeletal cells derived from human induced pluripotent stem cells, stroma cells derived from human induced pluripotent stem cells, and neuronal cells derived from human induced pluripotent stem cells; biological tissues, other than for medical or veterinary purposes, namely, tissues in particular engineered tissues, in particular tissue comprising cells derived from induced pluripotent stem cells and macroscale muscle tissue, in particular human heart muscle constructed from cardiomyocytes derived from human induced pluripotent stem cells, human skeletal muscle constructed from skeletal cells derived from human induced pluripotent stem cells, human fibrotic tissue constructed from stroma cells derived from human induced pluripotent stem cells, connective tissue constructed from connective tissue cells derived from human induced pluripotent stem cells, brain tissue derived from human induced pluripotent stem cells, and neuronal organoids; biological preparation for use in cell cultures other than for medical or veterinary use; biological tissue cultures, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes, namely disease models based on engineered tissue or engineered cells
5
Pharmaceutical and veterinary preparations, in particular cells and tissues; preparations for the renewal and regeneration of organs; cellular therapy products; tissue derived from stem cells; tissue-regenerative pharmaceutical preparations
9
Scientific research and laboratory apparatus; Cell culture apparatus for laboratory use, in particular cell culture plates and tissue culture plates for the generation and/or cultivation of engineered tissue
42
Scientific and industrial research in particular in the biochemical, diagnostic or pharmaceutical fields; Biochemical or pharmaceutical laboratory services, in particular in the field of cultivation of cells and tissues; Drug discovery services, in particular drug discovery services based on tissue engineered organ platforms; Scientific and technological services and research in the field of regenerative medicine; cell culture services for scientific and research purposes, for others
ID: 11018578237